SBIR-STTR Award

Truenamel: a Dental Product That Treats, Protects, Desensitizes and Whitens Teeth
Award last edited on: 4/10/19

Sponsored Program
STTR
Awarding Agency
NIH : NIDCR
Total Award Amount
$188,406
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Brian H Clarkson

Company Information

Truenamel LLC

3550 West Liberty Suite 3
Ann Arbor, MI 48103
   (734) 834-9793
   N/A
   www.truenamel.com

Research Institution

University of Michigan

Phase I

Contract Number: 1R41DE024011-01A1
Start Date: 4/1/15    Completed: 3/31/16
Phase I year
2015
Phase I Amount
$188,406
Dentin hypersensitivity is a painful condition affecting from 15%-60% of the population. It is caused by the movement of fluid in the dentinal tubules and can be eliminated by occluding these patent tubules. Tooth whitening is a $1.4 billion business in America and is predicted to grow both here and abroad. In this grant we propose a treatment for dentin hypersensitivity coupled with a tooth whitening agent. A nano (300-600 nm0 in length and 50-60 nm in cross section) fluor hydroxyapatite crystals (similar to enamel crystals in shape and composition) and is incorporated into a self etch resin which will bond to both enamel and dentin and can be tinted to be white or tooth colored - a paint on enamel. This novel agent, depending on the curing mechanism will be sold over-the-counter or used as an in-office treatment. We propose in this grant: to measure the bond strength to enamel and dentin; determine the penetration and coverage of tooth surfaces; substantivity; and effect on the hydraulic conductance of dentin by this desensitizing/tooth whitening agent. Three other features of this agent is its ability to release calcium, fluoride and phosphate at low pH which may help in preventing and repairing demineralized enamel and dentin caused by caries. It may also be used to treat and/or prevent erosion of enamel and dentin. It will stimulate dental pulp stem cells to mineralize, therefore forming a pulpal protective barrier in deep cavities. This 5 in1 product, TruEnamel, is unique and offers to consumers and dentists a therapeutic cosmetic with a market of approximately $2 billion.

Public Health Relevance Statement:


Public Health Relevance:
A proportion of the general public suffer from sensitive teeth, others from dental erosion as well as a large proportion would like to have white teeth and 95% suffer from dental decay. One treatment option for all these conditions would be an ideal product. This 5 in 1 product, TruEnamel, using synthetic enamel crystals and a resin that sticks to teeth offers a treatment for all of the above as an over the-counter-product or in-dental office treatment.

Project Terms:
Academy; Adhesives; Adult; Affect; American; Americas; Applications Grants; base; biomaterial development; Businesses; Calcium Fluoride; Clinical; Color; commercialization; Cosmetics; cost; Coupled; Dental; dental adhesive; Dental caries; Dental Enamel; Dental Esthetics; Dental Offices; Dental Pulp; Dentin; Dentin Sensitivity; Dentinal Fluid; Dentistry; Dentists; drinking; Eating; Effectiveness; Environment; experience; Filler; fluid flow; fluor-hydroxylapatite; General Population; Grant; Hydrogen Peroxide; Hypersensitivity; Incubators; Individual; inorganic phosphate; Intellectual Property; Ions; Laboratories; Legal patent; Length; Licensing; Liquid substance; Literature; Magic; Marketing; Measures; member; Michigan; Modality; Movement; Names; nano; Nerve Endings; novel; Oral; Outcome; Pain; Paint; Patients; Penetration; Peroxides; Pharmaceutical Preparations; Phase; Plant Resins; Population; pressure; prevent; Procedures; public health relevance; pulp capping material; repaired; Reporting; Research; Research Personnel; Shapes; Small Business Technology Transfer Research; soft tissue; Stem cells; success; Surface; surface coating; Technology; Testing; Therapeutic; Tooth structure; tooth surface; Tooth Tissue; toothbrush; Toothbrushing; Universities; Urea

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----